Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder
BBTI & PTSD
1 other identifier
interventional
200
1 country
1
Brief Summary
This study will investigate treatments for insomnia in Veterans who have posttraumatic stress disorder (PTSD). The purpose of this study is to compare a brief behavioral treatment for insomnia (BBTI) to a treatment that helps promote relaxation (progressive muscle relaxation training or PMRT). The investigators will examine improvements in psychosocial functioning and insomnia severity. The investigators will also examine whether treatment gains last over time and whether suicidal ideation decreases following insomnia treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2023
CompletedFirst Posted
Study publicly available on registry
March 22, 2023
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
April 21, 2026
April 1, 2026
4 years
March 9, 2023
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Work and Social Adjustment Scale (WSAS) Change
Assesses functioning in work, home management, social leisure activities, private leisure activities and relationships with others. It is a five-item measure with each item rated on a 0 to 8 scale, with higher scores reflecting greater impairment.
Change from baseline (Week 1) to posttreatment (Week 5)
Work and Social Adjustment Scale (WSAS) Change
Assesses functioning in work, home management, social leisure activities, private leisure activities and relationships with others. It is a five-item measure with each item rated on a 0 to 8 scale, with higher scores reflecting greater impairment.
Change from baseline (Week 1) to 6-month follow-up--for treatment arm only
Secondary Outcomes (2)
Insomnia Severity Index (ISI)
Change from baseline (Week 1) to posttreatment (Week 5)
Insomnia Severity Index (ISI)
Change from baseline (Week 1) to 6-month follow-up--for treatment arm only
Other Outcomes (2)
Depressive Symptom Index: Suicidality Subscale (DSI-SS)
Change from baseline (Week 1) to 6-month follow-up--for treatment arm only
Depressive Symptom Index: Suicidality Subscale (DSI-SS)
Change from baseline (Week 1) to posttreatment (Week 5)
Study Arms (2)
BBTI
EXPERIMENTALParticipants in this arm will receive 4 sessions (30-60 minutes) of a brief behavioral treatment for insomnia (BBTI). Relaxation techniques are not a component of BBTI.
PMRT
ACTIVE COMPARATORParticipants in this arm will receive 4 sessions (30-60 minutes) of progressive muscle relaxation training (PMRT).
Interventions
Participants in this arm will receive 4 sessions (30-60 minutes) of progressive muscle relaxation training called PMRT.
Participants in this arm will receive 4 sessions (30-60 minutes) of a brief behavioral treatment for insomnia called BBTI. Relaxation techniques are not a component of BBTI.
Eligibility Criteria
You may qualify if:
- Individuals between the ages of 18-75 years who served in the military
- Veterans who meet DSM-5 Criteria for Insomnia Disorder.
- Veterans who meet DSM-5 Criteria for current PTSD
- If currently taking insomnia, PTSD or other psychotropic medications, must be stable on these medications for at least one month and not make any changes to medications during the active treatment phase of the study.
- If currently receiving any type of psychotherapy, must have received this treatment for at least one month and do not plan to discontinue treatment during the BBTI trial. Individuals planning to start a new type of psychotherapy will be required to wait one month prior to study enrollment. Individuals currently engaged or planning to engage in evidence-based treatments that are recognized by the VA as directly targeting insomnia or PTSD (i.e., Cognitive Behavioral Therapy for Insomnia, Cognitive Processing Therapy, or Prolonged Exposure Therapy) must complete treatment and wait one month prior to screening for the trial.
- The investigators will not exclude individuals with TBI, given that prior studies have found that individuals with mild to severe TBI can benefit from behavioral interventions for insomnia.
- The investigators will not exclude individuals with chronic pain, given that prior studies have found that these individuals can benefit from behavioral interventions for insomnia.
- The investigators will not exclude individuals with treated sleep apnea or untreated sleep apnea or individuals that are high-risk for sleep apnea. Prior research has found that these individuals can benefit from behavioral interventions for insomnia. Recent research has also established that individuals with untreated mild, moderate or severe sleep apnea or those high-risk for sleep apnea are more likely to receive assessment and treatment for this condition after completing behavioral treatment for insomnia.
You may not qualify if:
- Veterans with a lifetime history of psychotic disorder or manic episodes.
- Veterans with moderate to severe alcohol or substance use disorder.
- Veterans with recent homicidal behaviors. Veterans with suicidal ideation will not be excluded. However, Veterans with recent suicidal behaviors or hospitalization or those who report prominent suicidal ideation with intent or a plan will be excluded.
- Veterans who are pregnant
- Veterans who work night or rotating shifts
- Veterans with unstable housing
- Veterans with untreated medical conditions that are known to affect sleep (e.g., restless legs syndrome)
- Veterans with uncontrolled seizure disorder. Sleep restriction is contraindicated for people with uncontrolled seizures due to the possibility of triggering a seizure.
- Veterans who are unable to participate in video treatment sessions or complete online surveys.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
San Francisco VA Medical Center, San Francisco, CA
San Francisco, California, 94121-1563, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shira Maguen, PhD
San Francisco VA Medical Center, San Francisco, CA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The clinical evaluator will be kept blind to treatment condition throughout the study period.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2023
First Posted
March 22, 2023
Study Start
May 1, 2023
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
April 21, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share